Amphastar Pharmaceuticals (AMPH) Short-Term Debt issuances (2013 - 2025)

Amphastar Pharmaceuticals' Short-Term Debt issuances history runs 7 years deep, the most recent figure standing at $273000.0 for Q4 2025.

• In Q4 2025, Short-Term Debt issuances fell 94.39% year-over-year to $273000.0; the TTM figure through Dec 2025 stood at $6.2 million (down 66.28% YoY), while the FY2025 annual figure was $6.2 million, down 66.28% from the prior year.
• Short-Term Debt issuances was $273000.0 for Q4 2025 at Amphastar Pharmaceuticals, up from $172000.0 in the prior quarter.
• In the past five years, Short-Term Debt issuances ranged from a high of $500.0 million in Q2 2023 to a low of -$25000.0 in Q2 2024.
• Historically, Short-Term Debt issuances has averaged $58.3 million across 3 years, with a median of $4.1 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Short-Term Debt issuances plunged 100.0% in 2024, then jumped 16616.0% in 2025.
• A 3-year view of Short-Term Debt issuances shows it stood at $500.0 million in 2023, then slumped by 99.03% to $4.9 million in 2024, then sank by 94.39% to $273000.0 in 2025.
• The last three Short-Term Debt issuances figures came in at $273000.0 (Q4 2025), $172000.0 (Q3 2025), and $4.1 million (Q2 2025), per Business Quant data.